Translation of "évaluation négative de l'avenir " (French → English) :

Definition: Events resulting in a negative self-reappraisal by the child such as failure in tasks with high personal investment; disclosure or discovery of a shameful or stigmatizing personal or family event; and other humiliating experiences.

negative assessment

Guidelines for Testing and Reporting of Antimicrobial Susceptibilities of Methicillin Resistant Staphylococus aureus (MRSA) and Commentary on Methicillin Resistant Coagulase Negative Staphylococci (MR-CNS)

Sustainable for the income capacity of the institution under point (a) of Article 78(1) of Regulation (EU) No 575/2013 shall mean that the profitability of the institution, as assessed by the competent authority, continues to be sound or does not see any negative change after the replacement of the instruments with own funds instruments of equal or higher quality, at that date and for the foreseeable future.

(Return tabled) Question No. 848 Mr. Matthew Kellway: With regard to the National Shipbuilding Procurement Strategy (NSPS): (a) has a statement of operational requirements been established, (i) if yes, when was this done and what are the criteria that will be used to determine what ships will be built, (ii) if no, when will it be done, (iii) if it will not be done, what criteria will be used to determine what ships will be built; (b) will there be an open competition for contracts associated with the strategy; (c) what is a current breakdown of the $35 billion contract value that was assessed, specifically, what is the value of each individual component included in this assessed value; (d) where will the technology being used to build th ...[+++]e ships come from; (e) what components will be included in each ship (i.e., hull, weapons systems, propulsion, etc.); (f) will the ships have all components necessary for deployment, (i) if not, why not and which components will need to be procured at a future date, (ii) if yes, what contracts have been signed that to account for this answer; (g) how will the contracts be awarded, specifying (i) how many ships will be built, (ii) which shipyards will be used for construction, (iii) what will be the dollar value of contracts awarded to each of the shipyards; (h) what are the details of any changes the government has made to the strategy and associated contracts as a result of delays in delivery (for example, in the case of the Arctic/Offshore Patrol Ships (AOPS)) and what are the impacts of the delays in delivery on the overall cost of the project, identifying in particular whether and how delays have impacted the estimated $3.1 billion cost of the AOPS; (i) has there been an evaluation of how many jobs will be created by this strategy, if yes, (i) how many jobs are expected to be created and for what duration, (ii) who conducted this evaluation, (iii) have the job creation projections been independently verified, and, if yes, ...

(Return tabled) Question No. 390 Ms. Laurin Liu: With regard to the debris from the 2011 Japanese tsunami headed towards Canada’s west coast: (a) has there been an environmental assessment done, (i) if so, what were the results, (ii) if not, why not; (b) has the government assessed the impact of this situation on Canada’s economy, (i) if so, what were the results, (ii) if not, why not; (c) has the government assessed the implications of radioactivity, (i) if so, what were the results, (ii) if not, why not; (d) has the government assessed the approximate timeline of this event ...[+++], (i) if so, what were the results, (ii) if not, why not; and (e) what are the titles of the studies or reports done, by or on behalf of the government, that cover, in whole or in part, this event?

(Return tabled) Question No. 68 Ms. Kirsty Duncan: With respect to the Canadian HIV Vaccine Initiative (CHVI) and the Level 5 Laboratory (L5L): (a) what are the details of the initial request for proposals for the CHVI; (b) what amount were the government and the Gates Foundation planning to invest in the CHVI and what were the scheduled dates for investment; (c) how many bids for the CHVI were submitted and by which organizations; (d) what are the details of the CHVI process for determining suitable award winners; (e) what were the selection criteria for awarding the CHVI bid and who was responsible for identifying the criteria; (f ...[+++]) how many people made up the independent evaluation committee for the CHVI bids, how were they selected, and from which disciplines and geographic areas were they drawn; (g) were representatives from the pharmaceutical industry invited to be part of the independent evaluation committee for the CHVI bids and, if so, on what date did each representative serve and, if not, why not; (h) what were the results for each of the selection criterion for each of the organizations bidding on the CHVI and how were the bids ranked; (i) did the independent evaluation committee for the CHVI bids reach a recommendation, and, if so, on what date, and to whom was the information conveyed in the government; (j) was there a steering committee for the CHVI bids and, if so, who were the members, who was the chair and what was its mandate; (k) were there changes to the steering committee for the CHVI bids and, if so, on what dates and for what reasons; (l) was any organization bidding on the CHVI informed, formally or otherwise, that it had been chosen to host the facility and, if so, how and on what date; (m) did the federal government put up a notice on its Web site to announce that the CHVI project had been cancelled or would not proceed and, if so, on what date; (n) was the notice in (m) removed from the Web site and, if so, on what date and fo ...